Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Aurinia Pharmaceuticals Inc AUPH

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.


Top institutional share ownership of Aurinia Pharmaceuticals Inc

Name Shares Shares % change Value Value % change
BlackRock Inc. 7,713,055 -1.3% $58,002 -26.1%
Deep Track Capital, LP 5,677,372 $42,694
Fmr Llc 4,994,705 2.2% $37,560 -23.6%
NEA Management Company, LLC 3,969,834 0.0% $29,853 -25.2%
IWM - iShares Russell 2000 ETF 2,887,871 -5.2% $21,717 -29.1%
Bellevue Group AG 2,846,457 6.6% $21,405 -20.3%
Citadel Advisors Llc 2,750,116 216.4% $20,681 136.7%
State Street Corp 2,441,434 2.2% $18,360 -23.5%
FAGAX - Fidelity Advisor Growth Opportunities Fund Class A 1,825,600 0.0% $13,436 -34.8%
Morgan Stanley 1,467,029 -49.3% $11,031 -62.0%

Top institutional buyers of Aurinia Pharmaceuticals Inc

Name Shares % change Value % change Shares Value
Citadel Advisors Llc 216.4% 136.7% 2,750,116 $20,681
Balyasny Asset Management Llc 71.0% 28.0% 853,787 $6,420
Rock Springs Capital Management LP 30.8% -2.1% 1,066,408 $8,019
Renaissance Technologies Llc 22.6% -8.3% 733,800 $5,518
Bellevue Group AG 6.6% -20.3% 2,846,457 $21,405
Geode Capital Management, Llc 3.6% -22.5% 1,204,982 $9,061
Vanguard Group Inc 3.3% -22.7% 1,207,609 $9,081
State Street Corp 2.2% -23.5% 2,441,434 $18,360
Fmr Llc 2.2% -23.6% 4,994,705 $37,560
IBB - iShares Nasdaq Biotechnology ETF 0.3% -25.0% 979,901 $7,369

Top institutional sellers of Aurinia Pharmaceuticals Inc

Name Shares % change Value % change Shares Value
Susquehanna International Group, Llp -54.8% -66.2% 776,381 $5,838
Morgan Stanley -49.3% -62.0% 1,467,029 $11,031
FBTAX - Fidelity Advisor Biotechnology Fund Class A -31.0% -45.1% 678,900 $5,553
Stifel Financial Corp -7.1% -30.5% 967,931 $7,279
IWM - iShares Russell 2000 ETF -5.2% -29.1% 2,887,871 $21,717
Northern Trust Corp -1.4% -26.2% 1,004,868 $7,557
Citigroup Inc -1.3% -26.1% 850,680 $6,397
BlackRock Inc. -1.3% -26.1% 7,713,055 $58,002
IWO - iShares Russell 2000 Growth ETF -0.9% -25.8% 1,033,693 $7,773

Information provided by Fintel.io